CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 5, Pages 1253
Publisher
MDPI AG
Online
2020-05-18
DOI
10.3390/cancers12051253
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemotherapy markedly reduces B cells but not T cells and NK cells in patients with cancer
- (2020) Johanna Waidhauser et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Microenvironment, Metabolism, and Immunotherapy
- (2020) Ralph J. DeBerardinis NEW ENGLAND JOURNAL OF MEDICINE
- Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers
- (2020) Ha Thi Thu Do et al. Cancers
- Molecular Profiling In Muscle Invasive Bladder Cancer: More Than The Sum Of Its Parts
- (2019) Gottfrid Sjödahl et al. JOURNAL OF PATHOLOGY
- Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
- (2019) Jason A. Efstathiou et al. EUROPEAN UROLOGY
- The Tumor Immune Microenvironment Drives a Prognostic Relevance that Correlates with Bladder Cancer Subtypes
- (2019) Carolin Pfannstiel et al. Cancer Immunology Research
- The Natural History of Untreated Muscle Invasive Bladder Cancer
- (2019) Alberto Martini et al. BJU INTERNATIONAL
- A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
- (2019) Aurélie Kamoun et al. EUROPEAN UROLOGY
- Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy
- (2019) Wentao Zhang et al. Annals of Translational Medicine
- Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
- (2019) Robert D. Leone et al. SCIENCE
- CCL2 promotes macrophages-associated chemoresistance via MCPIP1 dual catalytic activities in multiple myeloma
- (2019) Ruyi Xu et al. Cell Death & Disease
- Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications
- (2019) Magdalene Joseph et al. Frontiers in Oncology
- The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?
- (2018) Teizo Yoshimura Cellular & Molecular Immunology
- A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy
- (2018) Markus Eckstein et al. Oncotarget
- Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors
- (2018) Tuan Zea Tan et al. EUROPEAN UROLOGY
- CC Chemokine Ligand 18 Promotes Cell Proliferation and Metastasis of Urothelial Carcinoma via Activating PI3K/mTOR Signaling in Patient with Renal Transplantation
- (2018) Song Bo et al. UROLOGIA INTERNATIONALIS
- LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment
- (2018) Changhao Chen et al. Nature Communications
- Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma
- (2018) Yan-Li Li et al. ANNALS OF HEMATOLOGY
- Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study
- (2018) Yadong Guo et al. Cancer Management and Research
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
- (2017) Roland Seiler et al. EUROPEAN UROLOGY
- Notch Shapes the Innate Immunophenotype in Breast Cancer
- (2017) Qiang Shen et al. Cancer Discovery
- Non-muscle-invasive bladder cancer: a vision for the future
- (2017) Per-Uno Malmström et al. Scandinavian Journal of Urology
- Bladder cancer
- (2017) Oner Sanli et al. Nature Reviews Disease Primers
- The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review
- (2016) Michele Marchioni et al. Clinical Genitourinary Cancer
- CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
- (2016) Ryuichiro Arakaki et al. Cancer Medicine
- Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
- (2016) Vipulkumar Dadhania et al. EBioMedicine
- Unknown
- (2015) Helge Taubert et al. MOLECULAR MEDICINE
- Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals
- (2015) Qun Rao et al. Oncotarget
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Inflammatory Biomarkers and Bladder Cancer Prognosis: A Systematic Review
- (2014) Alexandra Masson-Lecomte et al. EUROPEAN UROLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- High coexpression ofCCL2andCX3CL1is gender-specifically associated with good prognosis in soft tissue sarcoma patients
- (2014) Astrid Kehlen et al. INTERNATIONAL JOURNAL OF CANCER
- Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
- (2014) J. S. Damrauer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bladder cancer invasion predictability based on preoperative neutrophil–lymphocyte ratio
- (2014) Mehmet Kaynar et al. TUMOR BIOLOGY
- Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors11Grant support: The Swedish Cancer Society, the Swedish research council, the Nilsson Cancer foundation, the BioCARE Strategic Cancer Research program, the Lund Medical Faculty, and FoU Landstinget Kronoberg and Södra Regionvårdnämnden.
- (2014) Gottfrid Sjödahl et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Protective Role of the Inflammatory CCR2/CCL2 Chemokine Pathway through Recruitment of Type 1 Cytotoxic T Lymphocytes to Tumor Beds
- (2013) T. Lanca et al. JOURNAL OF IMMUNOLOGY
- Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance
- (2012) Xiao-wei Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- Recruitment of a myeloid cell subset (CD11b/Gr1mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis*
- (2012) Lei Zhao et al. HEPATOLOGY
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- The Expression of Monocyte Chemotactic Protein-1 in Papillary Thyroid Carcinoma Is Correlated with Lymph Node Metastasis and Tumor Recurrence
- (2008) Katsuhiro Tanaka et al. THYROID
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started